6-151786801-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001122742.2(ESR1):​c.-70-21042A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.287 in 151,736 control chromosomes in the GnomAD database, including 7,675 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7675 hom., cov: 31)

Consequence

ESR1
NM_001122742.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.26

Publications

2 publications found
Variant links:
Genes affected
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]
ESR1 Gene-Disease associations (from GenCC):
  • estrogen resistance syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.482 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001122742.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESR1
NM_001122742.2
c.-70-21042A>G
intron
N/ANP_001116214.1G4XH65
ESR1
NM_001385568.1
c.-70-21042A>G
intron
N/ANP_001372497.1P03372-1
ESR1
NM_001385570.1
c.-70-21042A>G
intron
N/ANP_001372499.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESR1
ENST00000404742.5
TSL:1
c.-70-21042A>G
intron
N/AENSP00000385373.1Q5T5H8
ESR1
ENST00000473497.5
TSL:1
n.205-21042A>G
intron
N/A
ESR1
ENST00000440973.5
TSL:5
c.-70-21042A>G
intron
N/AENSP00000405330.1P03372-1

Frequencies

GnomAD3 genomes
AF:
0.287
AC:
43505
AN:
151618
Hom.:
7659
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.488
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.345
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.334
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.218
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.258
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.287
AC:
43587
AN:
151736
Hom.:
7675
Cov.:
31
AF XY:
0.287
AC XY:
21302
AN XY:
74116
show subpopulations
African (AFR)
AF:
0.488
AC:
20186
AN:
41376
American (AMR)
AF:
0.346
AC:
5270
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
429
AN:
3470
East Asian (EAS)
AF:
0.334
AC:
1718
AN:
5150
South Asian (SAS)
AF:
0.166
AC:
796
AN:
4802
European-Finnish (FIN)
AF:
0.218
AC:
2284
AN:
10466
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12166
AN:
67910
Other (OTH)
AF:
0.259
AC:
545
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1431
2862
4292
5723
7154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
1070
Bravo
AF:
0.308
Asia WGS
AF:
0.278
AC:
965
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.34
DANN
Benign
0.37
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12661437; hg19: chr6-152107936; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.